Bank of New York Mellon’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-224,805
| Closed | -$7.74M | – | 4296 |
|
|
2020
Q3 | $7.74M | Sell |
224,805
-7,664
| -3% | -$264K | ﹤0.01% | 1984 |
|
|
2020
Q2 | $3.89M | Buy |
232,469
+1,049
| +0.5% | +$17.5K | ﹤0.01% | 2340 |
|
|
2020
Q1 | $3.34M | Sell |
231,420
-431,739
| -65% | -$6.23M | ﹤0.01% | 2284 |
|
|
2019
Q4 | $22.2M | Sell |
663,159
-320,595
| -33% | -$10.7M | 0.01% | 1510 |
|
|
2019
Q3 | $20.6M | Buy |
983,754
+626,787
| +176% | +$13.1M | 0.01% | 1516 |
|
|
2019
Q2 | $7.43M | Buy |
356,967
+151,639
| +74% | +$3.16M | ﹤0.01% | 2132 |
|
|
2019
Q1 | $4.59M | Sell |
205,328
-347,878
| -63% | -$7.78M | ﹤0.01% | 2368 |
|
|
2018
Q4 | $13.2M | Buy |
553,206
+382,154
| +223% | +$9.14M | ﹤0.01% | 1754 |
|
|
2018
Q3 | $4.67M | Sell |
171,052
-714
| -0.4% | -$19.5K | ﹤0.01% | 2437 |
|
|
2018
Q2 | $4.62M | Buy |
171,766
+14,283
| +9% | +$384K | ﹤0.01% | 2437 |
|
|
2018
Q1 | $5.01M | Buy |
157,483
+23,898
| +18% | +$761K | ﹤0.01% | 2359 |
|
|
2017
Q4 | $5.05M | Sell |
133,585
-1,029
| -0.8% | -$38.9K | ﹤0.01% | 2355 |
|
|
2017
Q3 | $3.34M | Buy |
134,614
+3,261
| +2% | +$80.8K | ﹤0.01% | 2534 |
|
|
2017
Q2 | $2.7M | Buy |
131,353
+19,016
| +17% | +$391K | ﹤0.01% | 2665 |
|
|
2017
Q1 | $2.44M | Sell |
112,337
-23,901
| -18% | -$519K | ﹤0.01% | 2724 |
|
|
2016
Q4 | $2.79M | Buy |
136,238
+45,575
| +50% | +$932K | ﹤0.01% | 2656 |
|
|
2016
Q3 | $1.36M | Buy |
90,663
+8,002
| +10% | +$120K | ﹤0.01% | 3007 |
|
|
2016
Q2 | $895K | Buy |
82,661
+31,245
| +61% | +$338K | ﹤0.01% | 3215 |
|
|
2016
Q1 | $697K | Buy |
51,416
+6,867
| +15% | +$93.1K | ﹤0.01% | 3270 |
|
|
2015
Q4 | $822K | Buy |
44,549
+18,206
| +69% | +$336K | ﹤0.01% | 3281 |
|
|
2015
Q3 | $667K | Buy |
+26,343
| New | +$667K | ﹤0.01% | 3401 |
|